Perez, L. E., Fernandez, H., Ayala, E., Beato, F., Neuger, A., Pidala, J., . . . Anasetti, C. (2016). Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors. Bone Marrow Transplant.
Chicago-стиль цитированияPerez, Lia Elena, Hugo Fernandez, Ernesto Ayala, Francisca Beato, Anthony Neuger, Joseph Pidala, Michael J. Schell, and Claudio Anasetti. "Visilizumab With Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors." Bone Marrow Transplant 2016.
MLA-цитированиеPerez, Lia Elena, et al. "Visilizumab With Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors." Bone Marrow Transplant 2016.